BPA
TMO icon

Beacon Pointe Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Beacon Pointe Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Sell
37,709
-1,108
-3% -$532K 0.09% 217
2026
Q1 		$19.1M Buy
38,817
+19,461
+101% +$10.6M 0.1% 195
2025
Q4 		$11.2M Sell
19,356
-171
-0.9% -$96.7K 0.08% 234
2025
Q3 		$9.47M Sell
19,527
-13,836
-41% -$6.44M 0.08% 235
2025
Q2 		$13.5M Sell
33,363
-4
-0% -$1.67K 0.14% 140
2025
Q1 		$16.6M Buy
33,367
+2,660
+9% +$1.44M 0.19% 118
2024
Q4 		$16M Sell
30,707
-4,597
-13% -$2.53M 0.18% 126
2024
Q3 		$21.8M Sell
35,304
-719
-2% -$426K 0.25% 92
2024
Q2 		$19.9M Buy
36,023
+461
+1% +$264K 0.24% 97
2024
Q1 		$20.7M Sell
35,562
-16,122
-31% -$9.05M 0.23% 103
2023
Q4 		$27.4M Buy
51,684
+2,944
+6% +$1.42M 0.33% 65
2023
Q3 		$24.7M Buy
48,740
+13,746
+39% +$7.32M 0.31% 78
2023
Q2 		$18.3M Sell
34,994
-3,332
-9% -$1.8M 0.3% 76
2023
Q1 		$22.1M Buy
38,326
+5,663
+17% +$3.19M 0.38% 64
2022
Q4 		$18M Buy
32,663
+904
+3% +$479K 0.35% 73
2022
Q3 		$16.1M Sell
31,759
-737
-2% -$412K 0.36% 71
2022
Q2 		$17.7M Sell
32,496
-10,778
-25% -$5.93M 0.37% 65
2022
Q1 		$25.6M Buy
43,274
+20,950
+94% +$12M 0.35% 65
2021
Q4 		$14.9M Sell
22,324
-8,908
-29% -$5.56M 0.39% 60
2021
Q3 		$17.8M Buy
31,232
+23,690
+314% +$13M 0.44% 54
2021
Q2 		$3.8M Buy
7,542
+3,857
+105% +$1.82M 0.13% 153
2021
Q1 		$1.68M Sell
3,685
-434
-11% -$207K 0.1% 155
2020
Q4 		$1.92M Buy
4,119
+592
+17% +$278K 0.13% 133
2020
Q3 		$1.56M Buy
3,527
+663
+23% +$274K 0.15% 126
2020
Q2 		$1.04M Buy
2,864
+680
+31% +$228K 0.1% 162
2020
Q1 		$621K Buy
+2,184
New +$689K 0.1% 154

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Beacon Pointe Advisors's TMO Position: Q2 2026 in Review

Beacon Pointe Advisors reduced its Thermo Fisher Scientific (TMO) stake by 2.9% in Q2 2026, selling an estimated $532K and leaving 37,709 shares worth $18.9M. The position accounts for 0.09% of the portfolio, ranked #217.

Beacon Pointe Advisors first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $27.4M in Q4 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Beacon Pointe Advisors held 37,709 shares of Thermo Fisher Scientific worth $18.9M as of Q2 2026.
  • Beacon Pointe Advisors sold 1,108 Thermo Fisher Scientific shares in Q2 2026, an estimated $532K.
  • Thermo Fisher Scientific made up 0.09% of Beacon Pointe Advisors's portfolio in Q2 2026, its #217 holding.
  • Beacon Pointe Advisors first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • Beacon Pointe Advisors's Thermo Fisher Scientific position peaked at $27.4M in Q4 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.